PMC:7600245 / 25347-25489
Annnotations
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T235 | 125-135 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T345 | 38-50 | Chemical | denotes | sulfate salt | http://purl.obolibrary.org/obo/CHEBI_35175 |
T346 | 38-45 | Chemical | denotes | sulfate | http://purl.obolibrary.org/obo/CHEBI_16189 |
T347 | 46-50 | Chemical | denotes | salt | http://purl.obolibrary.org/obo/CHEBI_24866|http://purl.obolibrary.org/obo/CHEBI_26710 |
T349 | 56-60 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T185 | 0-142 | Sentence | denotes | Following oral administration as hemi-sulfate salt, the drug gets converted to the monophosphate form via multiple metabolic activation steps. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
723 | 33-50 | Chemical | denotes | hemi-sulfate salt |
724 | 83-96 | Chemical | denotes | monophosphate |